Oncomine Tumor Mutation Burden (TMB) and Microsatellite Instability (MSI) Test
The Oncomine Tumor Mutation Burden (TMB) and Microsatellite Instability (MSI) test is a cutting-edge diagnostic tool that plays a crucial role in the field of oncology. This test is designed to evaluate the genetic landscape of tumors, providing invaluable insights that can guide targeted therapies and improve patient outcomes.
Importance of the Test
Understanding the genetic mutations within a tumor is essential for effective cancer management. The Oncomine TMB and MSI test helps oncologists determine the best course of treatment based on the tumor’s genetic profile. By identifying mutations and instability within microsatellite regions, this test aids in predicting how a patient may respond to certain therapies.
What the Test Measures
- Tumor Mutation Burden (TMB): This measures the total number of mutations within the tumor’s DNA.
- Microsatellite Instability (MSI): This assesses the stability of microsatellite regions, which can indicate a higher likelihood of certain cancer types.
Who Should Consider This Test?
This test is recommended for patients diagnosed with cancer, especially those exhibiting specific symptoms or risk factors, such as:
- Family history of cancer
- Presence of certain tumor types
- Patients considering immunotherapy
Benefits of Taking the Test
- Guides personalized treatment plans based on genetic findings.
- Helps in identifying potential eligibility for clinical trials.
- Provides insights into the aggressiveness of the tumor.
Understanding Your Results
Results from the Oncomine TMB and MSI test are interpreted by qualified oncologists. A higher TMB can indicate a better response to immunotherapy, while MSI status can help identify patients who may benefit from specific cancer treatments. It is essential to discuss your results with your healthcare provider to understand their implications fully.
Test Details
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Oncomine Tumor Mutation Burden (TMB) and Microsatellite Instability (MSI) | 105,000 KSh | 140,000 KSh |
Sample Collection and Instructions
The test requires a sample of tumor tissue and peripheral blood, specifically paraffin-embedded tissue blocks and an EDTA Vacutainer (3 ml). It is important to note that the Oncomine TMB and MSI test can only be conducted with a Doctor’s prescription. However, this prescription is not applicable for patients undergoing surgery, those who are pregnant, or individuals planning to travel abroad.
Branches Across Kenya
We have branches in all major cities across Kenya, ensuring that you have easy access to our diagnostic services. For your convenience, we also offer home sample collection services.
Book Your Test Today!
Don’t wait to get the insights you need for effective cancer treatment. Call or WhatsApp us at +254711564616 to book the Oncomine Tumor Mutation Burden (TMB) and Microsatellite Instability (MSI) test today!
